1ST TRIMESTER PRENATAL-DIAGNOSIS OF TAY-SACHS DISEASE USING THE SULFATED SYNTHETIC SUBSTRATE FOR HEXOSAMINIDASE-A

被引:2
作者
CALLAHAN, JW
ARCHIBALD, A
SKOMOROWSKI, MA
SHUMAN, C
CLARKE, JTR
机构
[1] HOSP SICK CHILDREN,DEPT PEDIAT,TORONTO M5G 1X8,ONTARIO,CANADA
[2] HOSP SICK CHILDREN,RES INST,TORONTO M5G 1X8,ONTARIO,CANADA
[3] UNIV TORONTO,DEPT BIOCHEM,TORONTO M5S 1A1,ONTARIO,CANADA
[4] UNIV TORONTO,DEPT MED GENET,TORONTO M5S 1A1,ONTARIO,CANADA
关键词
chorionic villus samples; cultured villus cells; hexosaminidase A; MUGS; prenatal diagnosis; Tay-Sachs disease; β-galactosidase;
D O I
10.1016/0009-9120(90)80045-K
中图分类号
R446 [实验室诊断]; R-33 [实验医学、医学实验];
学科分类号
1001 ;
摘要
Uncultured and cultured embryonic trophoblastic tissue obtained by chorionic villus sampling (CVS) displays enzyme activity towards 4-methylumbelliferyl-2-acetamido-2-deoxy-β-D-glucopyranosyl-6-sulfate (MUGS), a specific substrate for Hexosaminidase A (Hex A), the enzyme deficient in Tay-Sachs disease (TSD). Specific activity is comparable to that found in cultured amniocytes and fibroblasts. The enzyme activity has a pH optimum of 4.1 and an apparent Km of 6 × 10- 4 mol/L. Thirteen pregnancies in eight families at risk for TSD were monitored by CVS using MUGS as the Hex A substrate. Four fetuses were proven affected by enzyme analysis of fetal tissues and cultured fetal fibroblasts obtained at the time of termination of the pregnancies. Nine fetuses were judged to be unaffected. Eight babies were clinically normal while the other pregnancy is continuing. The use of MUGS as substrate for Hex A makes prenatal diagnosis by CVS of families at risk for TSD simple, direct and accurate. © 1990 The Canadian Society of Clinical Chemists.
引用
收藏
页码:533 / 536
页数:4
相关论文
共 12 条
  • [1] INTERMEDIATE FORMS OF HUMAN BETA-N-ACETYLHEXOSAMINIDASE LACK ACTIVITY TOWARDS 4-METHYLUMBELLIFERYL BETA-N-ACETYLGLUCOSAMINIDE 6-SULFATE
    BECCARI, T
    EMILIANI, C
    HOSSEINI, R
    ORLACCHIO, A
    STIRLING, JL
    [J]. BIOCHEMICAL JOURNAL, 1987, 244 (03) : 801 - 804
  • [2] 1ST TRIMESTER PRENATAL-DIAGNOSIS OF SANDHOFFS DISEASE
    GILES, L
    COOPER, A
    FOWLER, B
    SARDHARWALLA, IB
    DONNAI, P
    [J]. PRENATAL DIAGNOSIS, 1988, 8 (03) : 199 - 205
  • [3] GRABOWSKI GA, 1984, AM J HUM GENET, V36, P1369
  • [4] USE OF 4-METHYLUMBELLIFERYL-6-SULFO-2-ACETAMIDO-2-DEOXY-BETA-D-GLUCOPYRANOSIDE FOR PRENATAL-DIAGNOSIS OF TAY-SACHS DISEASE USING CHORIONIC VILLI
    GREBNER, EE
    WENGER, DA
    [J]. PRENATAL DIAGNOSIS, 1987, 7 (06) : 419 - 423
  • [5] PRENATAL-DIAGNOSIS FOR TAY-SACHS DISEASE USING CHORIONIC VILLUS SAMPLING
    GREBNER, EE
    JACKSON, LG
    [J]. PRENATAL DIAGNOSIS, 1985, 5 (05) : 313 - 320
  • [6] PRENATAL-DIAGNOSIS OF GM2 GANGLIOSIDOSES USING A FLUOROGENIC SULFATED SUBSTRATE
    INUI, K
    WENGER, DA
    FURUKAWA, M
    SUEHARA, N
    YUTAKA, Y
    OKADA, S
    TANIZAWA, O
    YABUUCHI, H
    [J]. CLINICA CHIMICA ACTA, 1986, 154 (02) : 145 - 150
  • [7] INUI K, 1984, CLIN GENET, V26, P318
  • [8] JONES CS, 1984, CAN J BIOCHEM CELL B, V62, P529, DOI 10.1139/o84-070
  • [9] PRENATAL DIAGNOSIS OF GM1-GANGLIOSIDOSIS
    LOWDEN, JA
    CUTZ, E
    CONEN, PE
    RUDD, N
    DORAN, TA
    [J]. NEW ENGLAND JOURNAL OF MEDICINE, 1973, 288 (05) : 225 - 228
  • [10] LOWRY OH, 1951, J BIOL CHEM, V193, P265